Children's Medical Center Dallas   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Dallas TX United States (1913)

Organization Overview

First Clinical Trial
2004
NCT00513617
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Children's Health | Children's Medical Center Dallas

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 2)

Anemia, Sickle Cell (Phase 2)

Athletic Injuries (Phase 1)

Bipolar Disorder (Phase 4)

Brain Concussion (Phase 1)

Brain Injuries (Phase 1)

Brain Injuries, Traumatic (Phase 1)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Disease (Phase 4)

Fistula (Phase 4)

Heart Arrest (Phase 1)

Hypospadias (Phase 4)

Neoplasms (Phase 2)

Wounds and Injuries (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 11